Jazz Pharmaceuticals plc announced that the first patient has been enrolled in a global Phase 2b clinical trial evaluating the safety and efficacy of...
BridGene Biosciences, Inc., a biotechnology company using a unique chemoproteomic technology to discover and develop small molecules for high value, traditionally undruggable targets, announced...
Ascensus Specialties, a leading U.S. based provider of specialty materials for life sciences and advanced technology markets, announced its acquisition of Wychem Limited, a...
Rational Vaccines, a company focused on revolutionizing the treatment and prevention of herpes to eradicate the disease, announced the launch of a clinical trial...
Synthetic Biologics, Inc., a diversified clinical-stage company developing therapeutics designed to treat diseases in areas of high unmet need, announced it has signed a...
